IP Library › Granted Patent US 8,340,760
Granted Patent B2
US 8,340,760 · App. 13/230,525 · Granted Dec 25, 2012

Electric modulation of sympathetic nervous system

Assignee: Advanced Neuromodulation Systems, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,340,760
App. No.
13/230,525
Granted
Dec 25, 2012
Kind
B2
Abstract

A method is described for the treatment of obesity or other disorders, by electrical activation or inhibition of the sympathetic nervous system. This activation or inhibition can be accomplished by electrically stimulating the greater splanchnic nerve or other portion of the sympathetic nervous system using an implantable pulse generator. This nerve activation can result in reduced food intake and increased energy expenditure. Reduced food intake may occur through a variety of mechanisms that reduce appetite and cause satiety. Increased adrenal gland hormone levels will result in increased energy expenditure. Fat and carbohydrate metabolism, which are also increased by sympathetic nerve activation, will accompany the increased energy expenditure.

Claims (11)

1. A method for treating diabetes, comprising:

monitoring a first patient parameter and a second patient parameter; and

electrically activating a splanchnic nerve in said patient so as to achieve a desired change in said second monitored parameter;

wherein the splanchnic nerve is selected from the group consisting of the greater splanchnic nerve, the lesser splanchnic nerve, and the least splanchnic nerve;

wherein said first monitored parameter comprises an arterial blood pressure; and

wherein said electrically activating comprises activating the sympathetic nervous system with stimulation parameters that keep the arterial blood pressure within safe limits.

2. The method as recited in claim 1 , wherein:

said second parameter comprises an insulin level; and

said electrically activating further comprises activating the splanchnic nerve to achieve a decreased insulin level.

3. The method as recited in claim 2 , wherein:

said electrically activating has a signal-on no greater than a signal-off time.

Continuity (8)
Division 11804449 · May 17, 2007
Division 10243612 · Sep 13, 2002
Provisional Application 60366750 · Mar 22, 2002
Provisional Application 60370311 · Apr 5, 2002
Provisional Application 60379605 · May 10, 2002
Provisional Application 60384219 · May 30, 2002
Provisional Application 60386699 · Jun 10, 2002
Related Publication 20110319969A1 · Dec 29, 2011